Never Say Never In CGT – Welcome To “Neverland”
When the United States (US) Food and Drug Administration (FDA) releases a new guidance, there can either be little fanfare, or a fervor that spreads across the drug development industry causing a great deal of chatter throughout the Biotech and Pharmaceutical landscape. On June 2, 2026, the FDA issued a new draft Guidance for Industry…
